Rafarma NewsRafarma Pharmaceuticals is working on a dietary supplement for the neurological deficits’ treatmentRafarma Pharmaceuticals, Inc. (OTC: RAFA), where one of the priorities is the anti-aging therapy development, is starting a scientific...